Jun 12, 2015 7:54 EST

MOZI-Q BY BCORP XERION DISPENSARY: for all outdoor enthusiasts who have reactions to bug bites

iCrowdNewswire - Jun 12, 2015

MOZI-Q BY BCORP XERION DISPENSARY

Mozi-Q of BCorp Xerion Dispensary is for all outdoor enthusiasts who have reactions to bug bites. Mozi-Q offers a new, easy-to-use oral repellent that allows you to fully enjoy the outdoors without being “bugged”. Mozi-Q is a homeopathic formula in the form of a chewable pill. Xerion is expanding from Canada to U.S. market and seeking expansion capital.

Xerion Dispensary is a homeopathic formulation and manufacturing company based in Calgary, AB. Xerion Dispensary strives to create products that provide safe and natural solutions to everyday concerns. Whether it’s new and innovative formulas or time-honoured remedies, Xerion Dispensary is dedicated to making a household name for homeopathy and its products.

WHAT SETS US APART

As the first oral insect repellent in the world, with approval for both adults and children, Mozi-Q has created a new category in the insect repellent market, so direct competitors do not exist. Mozi-Q has competition with DEET based insect repellents such as OFF and natural bug sprays containing citronella, and with repellent patches containing Thiamin.

Xerion Dispensary has designed its formula to reduce the frequency of bites as well as the reactions that people have to bites. No more itching and big red bumps! No more smelly sprays or stinky coils…what a great ally for camping, golfing, hiking, biking. This could revolutionize the whole outdoor experience! Some of the product’s features include:

  • It works within 30 minutes of taking it.
  • There are no side effects.
  • It works on other bugs aside from mosquitoes like ticks and head lice.
  • Product can be taken every 2-3 hours starting right before you go outside.
  • There are no contraindications.
  • Homeopathic medicine is by definition non-toxic.


With strong ties to Xerion Homoeopathie and the Western College of Homeopathic Medicine, Xerion Dispensary is in a unique position to formulate products with clinical appeal that are backed by rigorous academic research. Xerion Dispensary is poised to be the lead player in the growth of the homeopathic formulation and manufacturing industry, and to foster the ever-growing homeopathic movement by marketing products with mass appeal in a fresh, new way.

Below: Mozi-Q president Erin Bosch in Canada’s Shark Tank, Dragon’s Den

Picture
 

WHY WE BECAME A BCORP

We believe that business is a driving force for change, and becoming a BCorp provides us with a structure to create measurable, positive change.

Xerion dispensary strives to create a world where safe and reliable natural medicines are readily available to people who want to have the freedom of choice for their healthcare. This is a world that uses healthcare to promote strength, not teat weakness. Xerion dispensary sees a safe, affordable, non-toxic medicine being used in developing countries.

Xerion dispensary believes that people should go to work in a place where they can have fun and are actively changing the world. Xerion dispensary believes that dreams are meant to be acted upon, and encourages employees to work towards both personal and corporate goals.

 

INTERNATIONAL GROWTH PLANS

Xerion Dispensary is seeking investment to expand from Canada to international markets, especially the United States. The majority of the infrastructure required to launch this product is already successfully in place. This will greatly facilitate the future growth of the company as well as ensure that import/export is operated with absolute efficiency.

Currently, we are setup to appropriately sell our products to Health Canada standards. State of the art computer systems, shipping and receiving and phone systems are already in place. We are equipped to service stores in Canada and to deliver product to our international distributors.
Our team is built to allow us to effectively fill orders and respond to retailer, customer, and distributor inquiries, though we are positioned to expand as needed.

Contact Information:

Erin Bosch

View Related News >
support